PMC:7784824 / 8808-9179
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
169 | 260-263 | Gene | denotes | ANF | Gene:4878 |
170 | 119-137 | Species | denotes | Epstein-Barr virus | Tax:10376 |
171 | 155-172 | Species | denotes | Toxoplasma gondii | Tax:5811 |
172 | 288-296 | Species | denotes | patients | Tax:9606 |
173 | 314-324 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
174 | 333-346 | Species | denotes | coronaviruses | Tax:11118 |
175 | 139-142 | Species | denotes | EBV | Tax:10376 |
176 | 174-178 | Species | denotes | Toxo | Tax:5811 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T90 | 0-371 | Sentence | denotes | Furthermore, 9 potential cross-reactive sera were included, i.e. IgM positivity against Cytomegalovirus (CMV) (n = 2), Epstein-Barr virus (EBV) (n = 2) or Toxoplasma gondii (Toxo) (n = 1); samples positive for rheumafactor (RF) (n = 1) or anti-nuclear factor (ANF) (n = 1)) and sera from patients positive for non-SARS-CoV-2 endemic coronaviruses (OC43 and NL63) (n = 2). |